Faron Pharmaceuticals Oy received a notification of major holdings from Marko Salmi, a shareholder, on 20th June 2024. The reason for the notification was a change due to the Share Offering. As of the notification date, Marko Salmi holds 3.66% of voting rights attached to shares, which amounts to 2,645,079 voting rights. This represents an increase from the previous position of 2.52% and 2,634,679 voting rights.
The notification also includes details of financial instruments. However, no specific information regarding the financial instruments was provided in the notification. Marko Salmi, the person subject to the notification obligation, is not controlled by any natural person or legal entity and does not control any other undertaking holding an interest in the issuer.
The completion of the Faron Share Offering on 20th June 2024 in Turku, Finland was also mentioned in the notification. The completion date and place were provided as part of the additional information.
This notification provides an overview of the change in major holdings within Faron Pharmaceuticals Oy, offering insight into the voting rights and the shareholder's position following the Share Offering.